The production of antibodies as part of a drug development project can be useful either as a research or detection tool or as a treatment itself. When SARS-CoV-2 enters the human body, it creates an antigenic footprint that can be targeted by specific therapeutic antibodies. In this case, the service can be to identify new therapeutics antibodies or to test existing antibodies for their anti-SARS-CoV-2 activity.
This service is designed for Biotech companies developing SARS-CoV-2 new drugs.
Materials to provide
- Details about the project
Further details on the project may be requested.
You will be able to exchange directly with the experts after filling in the form below.
- Study following the specifications validated with the Expert